You are here: Industry Insights > Fujifilm

News List

Fujifilm pays Biogen nearly $1B for Denmark biologics site fiercepharma
August 13, 2019
Fujifilm has sealed the deal. With the completion of an $890 million, all-cash exchange with Biogen, the CDMO is now in possession of a biologics production facility in Denmark with about 800 employees.
Fujifilm Completes Acquisition of Biogen’s Manufacturing Site in Denmark contractpharma
August 05, 2019
Invests roughly $890 million in project.
Fujifilm completes acquisition of Biogen's Manufacturing Site in Denmark biospectrumasia
August 04, 2019
With the closing of this transaction, the Hillerød Manufacturing site is now the fourth biopharmaceutical manufacturing site of FUJIFILM Diosynth Biotechnologies
FUJIFILM Irvine Scientific to Construct Manufacturing Site in Europe contractpharma
July 03, 2019
FUJIFILM Irvine Scientific, Inc. plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan.
Fujifilm to Invest $10M in Continuous Processing Facility contractpharma
June 10, 2019
Novel, fully integrated continuous processing production system for the manufacture of biopharmaceuticals.
Fujifilm Opens Life Science Office in Massachusetts contractpharma
May 31, 2019
Cambridge site brings the company closer to (bio)pharma community in the area.
Fujifilm Accelerates Cell Line Devt. Timelines contractpharma
April 15, 2019
Introduces a 10-week timeline with its Apollo X Advanced Mammalian Expression System.
Fujifilm to acquire Biogen in a $890 M deal biospectrumasia
March 13, 2019
FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark ("Biogen Hillerød") from Biogen for ap
Biogen to sell biologics production site to Fujifilm for $890m pharmaceutical-technology
March 13, 2019
US-based Biogen has signed a share purchase agreement to sell its biologics manufacturing site in Hillerød, Denmark to Japanese tech company Fujifilm for a cash consideration of up to $890m.
Fujifilm plans $20M U.S. facility for burgeoning interest in stem cell treatments fiercepharma
January 10, 2019
A host of companies are developing regenerative treatments that lean on stem cells. Seeing an opportunity, Japan’s Fujifilm will build a U.S. stem cell manufacturing facility not only for its own efforts but also as a CDMO.

Previous page 1 2 3 4 5 Next page